myelodysplastic syndromes (MDS) | Aplastic Anemia and MDS International Foundation

myelodysplastic syndromes (MDS)

Ron Carlsen Beats Early Onset MDS; Grapples with Post-Transplant GVHD

Person's Name: 
Ron Carlsen

In August 2004, I was 42 and going through the annual checkup routine. I felt fine and had no reason to suspect anything was starting to go wrong. I was called back twice to have more labs done.

Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions: Myelodysplastic Syndromes

Author(s): 
Santini V
Primary Author: 
Santini V
Journal Title: 
Clin Lymphoma Myeloma Leuk
Original Publication Date: 
May 2018

In the past few months, 2 main streams of research have dominated the panorama of myelodysplastic syndrome (MDS) investigations: deepening the insight into the pathogenic role, hierarchy, and prognostic effect of somatic mutations and, as a consequence, into the effect of inherited congenital predisposing conditions and the second, quite interlinked with the first, analyzing inflammation and innate immunity in patients with MDS.

Bone Marrow Diseases: